SOLUtion Medical is developing a drug delivery device for patient-injected medications that require mixing directly prior to injection. The self-injection market is growing. Worldwide healthcare is trending towards more at-home treatments and pharma companies are seeking ways to deliver high-volume drugs for self-treatment in a timely manner. The self-injected drug delivery market is approximately $38B and has been growing at a CAGR of 19%. A large percentage of these drugs currently require lyophilization, and the FDA predicts 50% of all injectable drugs will require reconstitution in the near future.
SOLUtion’s beachhead market is a rescue autoinjector for individuals at risk of an adrenal crisis, a situation similar to anaphylaxis where a patient’s body experiences physical and mental debilitation requiring immediate injection of hydrocortisone sodium succinate (HSS). The current and only adrenal crisis rescue injection on the market comes in the form of the Act-o-Vial, a system requiring 14 user steps, including cumbersome drug mixing, prior to injection.
SOLUtion’s beachhead market is a rescue autoinjector for individuals at risk of an adrenal crisis, a situation similar to anaphylaxis where a patient’s body experiences physical and mental debilitation requiring immediate injection of hydrocortisone sodium succinate (HSS). The current and only adrenal crisis rescue injection on the market comes in the form of the Act-o-Vial, a system requiring 14 user steps, including cumbersome drug mixing, prior to injection.
Location: United States, Pennsylvania, Philadelphia
Employees: 1-10
Founded date: 2019
Investors 2
| Date | Name | Website |
| - | Nextfab | nextfab.co... |
| 27.07.2022 | Ben Frankl... | sep.benfra... |
Mentions in press and media 8
| Date | Title | Description |
| 02.08.2022 | Hair Scarves And Sea Life Savers Won Big At Pennovation Accelerator’s 2022 Pitch Day | Peach Brown, founder of Sledge Scarves, drove home the strength of her non-slip hair scarves by lifting a bowling ball with one in front of pitch judges. The feat of strength came during Pennovation Accelerator’s fifth annual pitch day on W... |
| 18.10.2021 | Ben Franklin Approved $2.1M in 12 Early Stage Companies | |
| 01.07.2021 | SOLUtion Medical, a drug delivery device startup out of NextFab, is ready ‘to get some gas in the gas tank’ | Most founders have a story explaining the moment they realized their product or tech solution could live on as a full-fledged business. Maybe they were trying to fix a technical redundancy, or envisioned a product that could save time and m... |
| 10.12.2020 | What’s coming up at MedCity INVEST Precision Medicine Day 3? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug develo... |
| 27.07.2020 | Medtech company Headway won Pennovation Accelerator’s 2020 virtual pitch day | Pennovation Center’s 2020 accelerator ended on July 16 with a virtual version of its Pitch Day event. Now in its third year, the six-week program supports 10 startups with business development and networking. On Pitch Day, each startup gave... |
| 11.06.2020 | Meet the 10 early-stage companies in Pennovation Accelerator’s 2020 cohort | Now in its third year, the Pennovation Center introduced summer 2020 cohort of the Pennovation Accelerator on Wednesday. Ten startups working in the software, medical device and consumer product fields were selected from 70 applications to ... |
| 26.04.2019 | AI, medical devices and sports tech startups land in NextFab’s accelerator | The spring cohort of makerspace NextFab’s RAPID accelerator program, which connects hardware startups with resources, includes companies in the artificial intelligence, medical devices, clean tech and sports tech spaces. The program, first ... |
| - | What’s coming up at MedCity INVEST Precision Medicine Day 3? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug develo... |